RHA^® is different than the current hyaluronic acid (HA) fillers on the market.  It was designed specifically dynamic facial wrinkles and folds.  This means it is resilient enough to move with the face.  Revance^®, the manufacturer of RHA^®, has enhanced the manufacturing process that helps preserve the natural structure of the HA molecules.  Therefore the molecules are more like the natural HA found in your skin.  This is the only FDA approved HA filler with an indication for dynamic wrinkles and folds.

RHA hit the European market first in 2015 and earned it’s FDA approval in 2020.  It has a proven clinical effectiveness duration of up to 15 months.

The RHA^® Collection

There are 3 products in the RHA^® Collection including RHA^®2, RHA^®3 and RHA^®4.

RHA^®2 & RHA^®3 are indicated for the correction of moderate to severe facial lines such as the nasolabial folds.

RHA^®4 is indicated for deep dermis injection for the correction of moderate to severe facial lines.